These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 18808729)

  • 1. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.
    Mackle T; Gendy SS; Walsh M; McConn-Walsh R; Costello RW; Walsh MT
    J Laryngol Otol; 2008 Dec; 122(12):1309-17. PubMed ID: 18808729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis.
    Wilson AM; Duong M; Crawford L; Denburg J
    Clin Exp Allergy; 2005 Jan; 35(1):39-44. PubMed ID: 15649264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
    Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
    J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids.
    Wright ED; Christodoulopoulos P; Small P; Frenkiel S; Hamid Q
    Laryngoscope; 1999 Apr; 109(4):551-6. PubMed ID: 10201739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
    Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
    Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal epithelial cells express IL-10 at levels that negatively correlate with clinical symptoms in patients with house dust mite allergy.
    Muller B; de Groot EJ; Kortekaas IJ; Fokkens WJ; van Drunen CM
    Allergy; 2007 Sep; 62(9):1014-22. PubMed ID: 17686104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
    de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
    Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
    Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
    Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge.
    Semik-Orzech A; Barczyk A; Wiaderkiewicz R; Pierzchala W
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):418-24. PubMed ID: 19927541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal endothelial interleukin-10 expression is negatively correlated with nasal symptoms after allergen provocation.
    Muller B; de Groot EJ; Kortekaas IJ; Fokkens WJ; van Drunen CM
    Allergy; 2009 May; 64(5):738-45. PubMed ID: 19383027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
    Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
    Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis.
    Fransson M; Adner M; Erjefält J; Jansson L; Uddman R; Cardell LO
    Respir Res; 2005 Sep; 6(1):100. PubMed ID: 16146574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intranasal azelastine on the response to nasal allergen challenge.
    Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
    Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
    Boot JD; de Kam ML; Mascelli MA; Miller B; van Wijk RG; de Groot H; Cohen AF; Diamant Z
    Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluticasone on neuropeptides in nasal lavage in persistent allergic rhinitis.
    Schäper C; Gustavus B; Koch B; Ewert R; Felix SB; Kunkel G; Noga O; Gläser S
    J Investig Allergol Clin Immunol; 2010; 20(3):214-21. PubMed ID: 20635787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of eosinophil cationic protein release in mite-allergic rhinitis after specific nasal provocation.
    Branco-Ferreira M; Palma-Carlos ML; Santos MC; Lopes AP; Palma-Carlos AG
    Allerg Immunol (Paris); 1998 Apr; 30(4):104, 107-11. PubMed ID: 9631691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.